Deep Dive Into Inari Medical Stock: Analyst Perspectives (5 Ratings)
Portfolio Pulse from Benzinga Insights
Inari Medical (NASDAQ:NARI) has been evaluated by 5 analysts over the past three months, with a mix of bullish and indifferent ratings. The average 12-month price target has decreased by 12.32% to $61.2. Recent analyst actions include both raises and lowers in ratings and price targets.
July 16, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Inari Medical has received mixed analyst ratings over the past three months, with a notable decrease in the average 12-month price target by 12.32% to $61.2. Recent analyst actions include both raises and lowers in ratings and price targets.
The mixed analyst ratings and the decrease in the average price target suggest a neutral short-term impact on Inari Medical's stock price. While some analysts have raised their ratings, others have lowered them, reflecting uncertainty in the market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100